UB Paderborn / Katalog / Suche / in CDI

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Blood, 2016-02, Vol.127 (7), p.869-881

2016

Volltextzugriff (PDF)

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

Nucleic acids research, 2015-02, Vol.43 (3), p.e19

2015

Volltextzugriff (PDF)

Host plant peptides elicit a transcriptional response to control the Sinorhizobium meliloti cell cycle during symbiosis

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (9), p.3561-3566

2014

Volltextzugriff (PDF)

Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis

Proceedings of the National Academy of Sciences - PNAS, 2014-05, Vol.111 (18), p.6540-6540

2014

Volltextzugriff (PDF)

Global analysis of cell cycle gene expression of the legume symbiont Sinorhizobium meliloti

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (9), p.3217-3224

2014

Volltextzugriff (PDF)

Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study

BMC cancer, 2012-09, Vol.12 (1), p.422-422, Article 422

2012

Volltextzugriff (PDF)

Institutional implementation of clinical tumor profiling on an unselected cancer population

JCI insight, 2016-11, Vol.1 (19), p.e87062-e87062

2016

Volltextzugriff (PDF)

Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Clinical cancer research, 2011-09, Vol.17 (17), p.5801-5811

2011

Volltextzugriff (PDF)

Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines

Human molecular genetics, 2016-11, Vol.25 (21), p.4819-4834

2016

Volltextzugriff (PDF)

Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines

BMC genomics, 2014-02, Vol.15 (1), p.93-93, Article 93

2014

Volltextzugriff (PDF)

Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization

Journal of neurochemistry, 2012-03, Vol.120 (6), p.881-890

2012

Volltextzugriff (PDF)

Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer

Pharmacogenetics and genomics, 2012-02, Vol.22 (2), p.105-116

2012

Volltextzugriff (PDF)

Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation

Drug metabolism and disposition, 2012-10, Vol.40 (10), p.1984

2012

Volltextzugriff (PDF)

Shared Genomic Segment Analysis: The Power to Find Rare Disease Variants

Annals of human genetics, 2012-11, Vol.76 (6), p.500-509

2012

Volltextzugriff (PDF)

Abstract 4381: A multi-omic characterization of PARP enzymes in cancer to identify novel monoPARP drug targets

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4381-4381

2020

Volltextzugriff (PDF)

Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay

Cold Spring Harbor molecular case studies, 2015-10, Vol.1 (1), p.a000307-a000307

2015

Volltextzugriff (PDF)

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system

Frontiers in genetics, 2013, Vol.4, p.166-166

2013

Volltextzugriff (PDF)

Abstract 381: Elevated PARP7 expression in select cancers identifies a target population for RBN-2397 therapy

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.381-381

2021

Volltextzugriff (PDF)

Abstract 48: RBN-2397: A potent and selective small molecule inhibitor of PARP7 that induces tumor-derived antitumor immunity dependent on CD8 T cells

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.48-48

2021

Volltextzugriff (PDF)

Abstract 3586: Comprehensive assessment of mouse contamination removal strategies from patient-derived xenograft model sequencing data

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3586-3586

2017

Volltextzugriff (PDF)

Abstract 3405: PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition leads to tumor regression

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3405-3405

2020

Volltextzugriff (PDF)

Abstract DDT02-01: RBN-2397: A first-in-class PARP7 inhibitor targeting a newly discovered cancer vulnerability in stress-signaling pathways

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.DDT02-01-DDT02-01

2020

Volltextzugriff (PDF)

Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study

BMC proceedings, 2009-12, Vol.3 Suppl 7 (Suppl 7), p.S46-S46, Article S46

2009

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Targetable genetic features of primary testicular and primary central nervous system lymphomas

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

Host plant peptides elicit a transcriptional response to control the Sinorhizobium meliloti cell cycle during symbiosis

Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis

Global analysis of cell cycle gene expression of the legume symbiont Sinorhizobium meliloti

Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease

Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study

Institutional implementation of clinical tumor profiling on an unselected cancer population

Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines

Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines

Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization

Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer

Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation

Shared Genomic Segment Analysis: The Power to Find Rare Disease Variants

Abstract 4381: A multi-omic characterization of PARP enzymes in cancer to identify novel monoPARP drug targets

Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system

Abstract 381: Elevated PARP7 expression in select cancers identifies a target population for RBN-2397 therapy

Abstract 48: RBN-2397: A potent and selective small molecule inhibitor of PARP7 that induces tumor-derived antitumor immunity dependent on CD8 T cells

Abstract 3586: Comprehensive assessment of mouse contamination removal strategies from patient-derived xenograft model sequencing data

Abstract 3405: PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition leads to tumor regression

Abstract DDT02-01: RBN-2397: A first-in-class PARP7 inhibitor targeting a newly discovered cancer vulnerability in stress-signaling pathways

Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study

Suchergebnisse filtern